1224443-47-3
1224443-47-3
Chemical Structure
Latanoprost acid-d4
- CAS No.: 1224443-47-3
- Formula:C23H30D4O5
- Molecular Weight:394.54
InChIKey: HNPFPERDNWXAGS-GPPKKVIBSA-N
SMILES: O[C@@H]1[C@@H]([C@H]([C@@H](C1)O)CC[C@H](CCC2=CC=CC=C2)O)C/C=C\C([2H])([2H])C([2H])([2H])CC(O)=O
Biological Activity: Latanoprost acid-d4 is used as the internal standard in the HPLC-MS/MS analysis to determine the level of Latanoprost acid (HY-113756A) in aqueous humor samples of eyes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Latanoprost acid-d4 | Latanoprost acid-d4 is used as the internal standard in the HPLC-MS/MS analysis to determine the level of Latanoprost acid (HY-113756A) in aqueous humor samples of eyes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Latanoprost acid (Standard) | ≥98% | Latanoprost acid (Standard) is the analytical standard of Latanoprost acid. This product is intended for research and analytical applications. Latanoprost acid, an analog of prostaglandin (PG) F2α, is an selective prostanoid receptor (FP) agonist that specifically activates the FP-PG receptor. Latanoprost acid inhibits RANKL-induced osteoclastgenesis and function by inhibiting ERK, AKT, JNK, and p38 cascade, following by the c-fos/NFATc1 pathway. Latanoprost acid is a medication which works to lower pressure inside the eyes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Latanoprost acid | 98.77% | Latanoprost acid, an analog of prostaglandin (PG) F2α, is an selective prostanoid receptor (FP) agonist that specifically activates the FP-PG receptor. Latanoprost acid inhibits RANKL-induced osteoclastgenesis and function by inhibiting ERK, AKT, JNK, and p38 cascade, following by the c-fos/NFATc1 pathway. Latanoprost acid is a medication which works to lower pressure inside the eyes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
